These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 11347156)

  • 21. Vascular consequences of menopause and hormone therapy: importance of timing of treatment and type of estrogen.
    Dubey RK; Imthurn B; Barton M; Jackson EK
    Cardiovasc Res; 2005 May; 66(2):295-306. PubMed ID: 15820198
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Role of hormone replacement therapy during menopause in the cardiovascular prevention].
    Turpin G
    Ann Cardiol Angeiol (Paris); 1994 Mar; 43(3):177-80. PubMed ID: 8024230
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hormone replacement therapy and the risk of stroke. Follow-up of a population-based cohort in Sweden.
    Falkeborn M; Persson I; Terént A; Adami HO; Lithell H; Bergström R
    Arch Intern Med; 1993 May; 153(10):1201-9. PubMed ID: 8388207
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hormonal replacement therapy--cardiovascular disease.
    Silfverstolpe G; Crona N
    Acta Obstet Gynecol Scand Suppl; 1986; 134():93-5. PubMed ID: 3028030
    [No Abstract]   [Full Text] [Related]  

  • 25. [Increased risk of breast cancer following hormone replacement therapy during climacteric. 3 440 extra cases might have been caused by the treatment in Sweden during the 1990s].
    Magnusson C; Reeves G
    Lakartidningen; 2005 Apr 18-24; 102(16):1228-30. PubMed ID: 15921095
    [No Abstract]   [Full Text] [Related]  

  • 26. Hormone replacement therapy to prevent coronary events.
    Richard D; Newton WP
    J Fam Pract; 1998 Nov; 47(5):333-4. PubMed ID: 9834761
    [No Abstract]   [Full Text] [Related]  

  • 27. Hormone replacement therapy and risk of heart disease.
    Elliott KK
    Am Fam Physician; 1999 Nov; 60(8):2234, 2237. PubMed ID: 10593314
    [No Abstract]   [Full Text] [Related]  

  • 28. Controversial aspects of hormone replacement therapy upon cardiovascular mortality and morbidity of women in menopause.
    Rosano GM; Mercuro G
    G Ital Cardiol; 1999 Sep; 29(9):999-1003. PubMed ID: 10514956
    [No Abstract]   [Full Text] [Related]  

  • 29. Which is the appropriate hormone replacement therapy after sub-total hysterectomy?
    Imoh-Ita F; Morgan P; Rymer J
    Climacteric; 2000 Mar; 3(1):65-7. PubMed ID: 11910612
    [No Abstract]   [Full Text] [Related]  

  • 30. [Treatment of osteoporosis with estrogen].
    Mizunuma H
    Nihon Rinsho; 2004 Feb; 62 Suppl 2():397-403. PubMed ID: 15035159
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects of hormone-replacement therapy on fibrinolysis in postmenopausal women.
    Koh KK; Mincemoyer R; Bui MN; Csako G; Pucino F; Guetta V; Waclawiw M; Cannon RO
    N Engl J Med; 1997 Mar; 336(10):683-90. PubMed ID: 9041098
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical feature and treatment of the postmenopausal hyperlipidemia].
    Tanaka K; Honjo H
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():766-70. PubMed ID: 11347170
    [No Abstract]   [Full Text] [Related]  

  • 33. HRT: forever or never?
    Corson SL
    Int J Fertil Womens Med; 2002; 47(4):150-1. PubMed ID: 12199410
    [No Abstract]   [Full Text] [Related]  

  • 34. The pharmacokinetics and efficacy of different estrogens are not equivalent.
    Ansbacher R
    Am J Obstet Gynecol; 2001 Feb; 184(3):255-63. PubMed ID: 11228470
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effect of hormone substitution therapy on AT III in women in the climacteric].
    Enzelsberger H; Heytmanek H; Kurz C; Metka M
    Zentralbl Gynakol; 1991; 113(11):639-44. PubMed ID: 1656654
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Hormonal treatment of the menopause and vascular pathology].
    Rozenbaum H
    J Mal Vasc; 1984; 9 Suppl A():32-4. PubMed ID: 6330256
    [No Abstract]   [Full Text] [Related]  

  • 37. [Hormone replacement therapy].
    Nozue E
    Nihon Rinsho; 1994 Mar; 52(3):787-92. PubMed ID: 8164383
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of transdermal estradiol and oral conjugated estrogens on haemostasis variables.
    Kroon UB; Silfverstolpe G; Tengborn L
    Thromb Haemost; 1994 Apr; 71(4):420-3. PubMed ID: 8052956
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Postmenopausal hormone therapy offers no protection against heart attacks.
    American Medical Association
    Ginecol Obstet Mex; 2002 Aug; 70():404-5. PubMed ID: 12448045
    [No Abstract]   [Full Text] [Related]  

  • 40. [Cyclical gestagen (MPA) supplement for continuous transdermal or oral estrogen substitution in postmenopause: modification of serum lipids].
    Hänggi W; Birkhäuser MH; Malek A; Peheim E; von Hospenthal JU
    Geburtshilfe Frauenheilkd; 1993 Oct; 53(10):709-14. PubMed ID: 8270155
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.